Robert Tyler

Robert Tyler is a seasoned executive with extensive experience in business development within the biopharmaceutical and pharmaceutical industries. Currently serving as Vice President of Global Strategic Biopharmaceutical Business Development at Actylis since January 2022, Robert also held the title of Senior Director Biopharma, contributing significantly to the development of the company's US business following its acquisition by ACETO in 2021. Prior to this role, Robert directed business development at A&C Your Global GMP Partner from January 2012 to January 2022, focusing on unique solutions for the Pharmaceutical, Biotech, and Vaccine Industries. Earlier in the career, Robert managed sales for the United States Pharmacopeia and served as a sales representative for National Starch and Chemical Company, addressing territory-specific technical issues. Robert holds an MBA in Strategic Management from The George Washington University School of Business and a BA in Chemistry from North Carolina State University.